Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Corticotropin
(D00146)		[1] Corticotropin[1] Corticotropin (D00146) 💬[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[7] 2, 13, 46, 75, 81, 84, 222 💬
2Corticotropin-releasing hormone
(D00146)		[2] Corticorelin,
Corticotropin		[2] Corticotropin (D00146),
Corticorelin 💬		[3] CRHR1,
CRHR2,
MC2R 💬		[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75 💬
3Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.
(D00146)		[1] Corticotropin[1] Corticotropin (D00146) 💬[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 81 💬
4H.P. Acthar Gel (repository corticotropin injection)
(D00146)		[1] Corticotropin[1] Corticotropin (D00146) 💬[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 13 💬
5Ovine Corticotropin-Releasing Hormone (oCRH)
(D00146)		[2] Corticorelin,
Corticotropin		[2] Corticotropin (D00146),
Corticorelin 💬		[3] CRHR1,
CRHR2,
MC2R 💬		[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75 💬
6Repository Corticotropin Injection
(D00146)		[1] Corticotropin[1] Corticotropin (D00146) 💬[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 2, 13, 46, 84, 222 💬